Inventor · disambiguated record
Phil Skolnick
Also filed as: SKOLNICK PHIL
15 granted patents·28 pending applications·251 citations·filing 1978–2024
93Inventor score
Files withSKOLNICK PHIL12OPIANT PHARMACEUTICALS INC7NEUROVANCE INC4AEGIS THERAPEUTICS LLC3OTSUKA AMERICA PHARMACEUTICAL INC3
Top patents by PatentIndex Score
43 records- 0191US9205074B21-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disordersNEUROVANCE INC·Filed 2014·Granted Dec 8, 2015·9 cites·24 claims
- 0291US8877798B21-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disordersNEUROVANCE INC·Filed 2013·Granted Nov 4, 2014·11 cites·27 claims
- 0390US8461196B21-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disordersSKOLNICK PHIL·Filed 2012·Granted Jun 11, 2013·12 cites·11 claims
- 0490US5086072ATreatment of mood disorders with functional antagonists of the glycine/nmda receptor complexUS HEALTH·Filed 1990·Granted Feb 4, 1992·121 cites·10 claims
- 0588US9737506B21-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disordersNEUROVANCE INC·Filed 2015·Granted Aug 22, 2017·5 cites·26 claims
- 0686US10039746B21-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disordersOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2017·Granted Aug 7, 2018·3 cites·24 claims
- 0778US8138377B2Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and useSKOLNICK PHIL·Filed 2007·Granted Mar 20, 2012·5 cites·2 claims
- 0876US9133159B21-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicamentsNEUROVANCE INC·Filed 2013·Granted Sep 15, 2015·1 cites·41 claims
- 0975US2023225961A1Methods, Parenteral Pharmaceutical Formulations, and Devices for the Prevention of Opioid OverdoseOPIANT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1073US6017957APartial agonists of the strychnine insensitive glycine modulatory site of the N-methyl-D-aspartate receptor complex as neuropsychopharmacological agentsUS HEALTH·Filed 1989·Granted Jan 25, 2000·20 cites·21 claims
- 1173US2024197719A1Formulations and methods for the prevention of opioid overdoseAEGIS THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 1271US2021023049A1Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric DisordersOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2020·Application pending·0 cites
- 1369US2021401827A1Methods, parenteral pharmaceutical formulations, and devices for the prevention of opioid overdoseOPIANT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1468US2023077724A1Methods and compositions for treating cannabinoid overdose with a cannabinoid receptor antagonistOPIANT PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1567US2019070148A1Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric DisordersOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 1667US2021275444A1Methods, parenteral pharmaceutical formulations, and devices for the prevention of opioid overdoseOPIANT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1766US11471437B2Compositions and methods for treating cannabinoid hyperemesis syndrome with a cannabinoid receptor antagonistOPIANT PHARMACEUTICALS INC·Filed 2020·Granted Oct 18, 2022·0 cites·26 claims
- 1866US2009233978A1Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric DisordersSKOLNICK PHIL·Filed 2008·Application pending·0 cites
- 1965US5428069ATreating cognition with, aminocyclopropanecarboxylic derivativesUS ARMY·Filed 1993·Granted Jun 27, 1995·27 cites·2 claims
- 2065US5280015A2-substituted adenosines and 2-substituted adenosine 5'-carboxamidesUS ARMY·Filed 1990·Granted Jan 18, 1994·30 cites·10 claims
- 2163US2024408004A1Compositions, devices, and methods for the treatment of overdose and reward-based disordersAEGIS THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 2260US2017204088A1Novel 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicamentsEUTHYMICS BIOSCIENCE INC·Filed 2017·Application pending·0 cites
- 2360US2007082940A1Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disordersSKOLNICK PHIL·Filed 2006·Application pending·0 cites
- 2459US9597315B21-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicamentsEUTHYMICS BIOSCIENCE INC·Filed 2015·Granted Mar 21, 2017·0 cites·38 claims
- 2558US12290596B2Compositions and methods for the treatment of opioid overdoseINDIVIOR INC·Filed 2022·Granted May 6, 2025·0 cites·2 claims
- 2654US2008269348A1Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And UseSKOLNICK PHIL·Filed 2007·Application pending·0 cites
- 2753US2021220346A1Formulations and methods for the prevention of opioid overdoseAEGIS THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 2852US2008009538A1Methods and compositions for the treatment of urinary incontinenceSKOLNICK PHIL·Filed 2006·Application pending·0 cites
- 2952US2008194696A1Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And UseSKOLNICK PHIL·Filed 2007·Application pending·0 cites
- 3051US2020397749A1Compositions and methods for treating acute cannabinoid overdose with a cannabinoid receptor antagonistOPIANT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3150US2020390691A1Compositions, devices, and methods for the treatment of overdose and reward-based disordersAEGIS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3248US2009069374A1Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods For Their Preparation And Their Use As MedicamentsSKOLNICK PHIL·Filed 2008·Application pending·0 cites
- 3347US2008045547A1Salts And Co-Crystals of Pyrazolopyrimidine Compounds, Compositions Thereof And Methods For Their Production And UseLIPPA ARNOLD S·Filed 2007·Application pending·0 cites
- 3446US2003092770A1Combination therapy for treatment of depressionFiled 2001·Application pending·0 cites
- 3546US2020179271A1Compositions and methods for treating acute cannabinoid overdose with a cannabinoid receptor antagonistOPIANT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3645US2008014272A1Compositions and Methods for Treatment of Chronic Pain ConditionsSKOLNICK PHIL·Filed 2007·Application pending·0 cites
- 3744US2008058535A1Methods and compositions for production, formulation and use of 1 aryl-3-azabicyclo[3.1.0]hexanesCHEN ZHENGMING·Filed 2007·Application pending·0 cites
- 3844US2007082939A1Methods and compositions for the treatment of neuropathies and related disordersLIPPA ARNOLD S·Filed 2006·Application pending·0 cites
- 3944US2006223875A1Methods and compositions for production, formulation and use of 1-aryl-3-azabicyclo[3.1.0]hexanesSKOLNICK PHIL·Filed 2006·Application pending·0 cites
- 4044US2017209415A1Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive disorders including nicotine addictionMCKINNEY ANTHONY ALEXANDER·Filed 2016·Application pending·0 cites
- 4142US4239744ARadioreceptor assay for benzodiazepines in plasma and other biological specimensU S OF AMERICA·Filed 1978·Granted Dec 16, 1980·7 cites·7 claims
- 4240US2005245517A12-pyridinyl[7-(substituted-pyridin-4-yl) pyrazolo[1,5-a]pyrimidin-3-yl]methanonesSKOLNICK PHIL·Filed 2005·Application pending·0 cites
- 4339US2005277639A12-Pyridinyl[7-(substituted-pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]methanonesSKOLNICK PHIL·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Phil Skolnick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →